HUMIRA (adalimumab) Dermatology Healthcare Professional Site
VARSITY Ulcerative Colitis Clinical Trial | Entyvio® (vedolizumab)
VARSITY Ulcerative Colitis Clinical Trial | Entyvio® (vedolizumab)
Long-Term Safety of Adalimumab (HUMIRA) in Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis in 29,987 Patients Representing 56,951 Patient-Years - ACR Meeting Abstracts
HUMIRA (adalimumab) Dermatology Healthcare Professional Site
A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis | Arthritis Research & Therapy | Full Text
HUMIRA® (adalimumab) for Rheumatoid Arthritis (RA)
Abbvie initiates new clinical trial to evaluate humira® (adalimumab) for the treatment of fingernail psoriasis - Drug Target Review
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - Gastroenterology
Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty‐six‐week phase 3 open‐label study - Yamasaki - 2020 - The Journal of Dermatology - Wiley Online Library
HUMIRA (adalimumab) Dermatology Healthcare Professional Site
Adalimumab: a review of the reference product and biosimilars | BS
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - Journal of the American Academy of Dermatology
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis | SpringerLink
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis | NEJM
![PDF] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial](https://d3i71xaburhd42.cloudfront.net/1f3ea24e842b7750dfbe6b098b7b1b52e074980f/5-Figure1-1.png "PDF] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial")
PDF] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
Taking Citrate-Free Humira: What Patients Need to Know
Adalimumab - Wikipedia
AbbVie's Humira sales continue to climb beyond its patent expiration - Clinical Trials Arena
Safety | Crohn's Disease (CD) | HUMIRA® (adalimumab)
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator- controlled phase 3 trial - The Lancet
BioSpace Feature: A Look at Miracle Drug Humira's Journey to Proven Efficacy | BioSpace
Phase III clinical trials conducted for adalimumab biosimilars; data... | Download Scientific Diagram
تويتر \ Dr T ² | 🙈 🙉 🙊 على تويتر: "Found this gem while going through old records: denial of Humira for #Crohns because it was deemed experimental. Forced me into
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial - The Lancet
Amgevita (adalimumab) for Rheumatoid Arthritis | Amgen
